---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-23-000025"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T01:58:05.015193+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CEO James Foster buys $1M of CRL stock, terminates sell plan

## Summary
- CEO James C. Foster purchased 5,620 shares at average price $178.05 on Nov 14, 2023.
- Total purchase price approximately $1.0 million in open market transactions.
- Terminated Rule 10b5-1 trading plan dated Feb 24, 2023 that allowed sale of up to 112,341 shares.
- Foster cited confidence in strategic direction and long-term growth prospects.

## SEC filing metadata
- accession: 0001100682-23-000025
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/0001100682-23-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/crl-20231114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-23-000025
- JSON: https://secwatch.observer/filing/0001100682-23-000025.json
- Plain text: https://secwatch.observer/filing/0001100682-23-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.